David R. Meuse
Known title: DirectorCIK: 0001223829
Associated companies
Transaction History
| IBP | ▲ Buy | Grant | 855 | $0 | 5/19/2026 | View on chart |
| IBP | ▲ Buy | Grant | 775 | $0 | 5/20/2025 | View on chart |
| IBP | ▲ Buy | Grant | 598 | $0 | 5/23/2024 | View on chart |
| IBP | ▲ Buy | Grant | 934 | $0 | 5/25/2023 | View on chart |
| IBP | ▲ Buy | Grant | 1,067 | $0 | 5/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
IBP Shares Fall as RBC Cuts Target and Melius Initiates Hold
Installed Building Products shares dropped alongside other industrial peers, partly due to RBC Capital lowering its price target to $208 and Melius Research initiating coverage with a Hold rating. While the stock is trading near its 52-week low, the average analyst target remains significantly higher at $239.92. The company also released its 2026 ESG report, but the recent focus has been on the mixed analyst outlook.
IBP Shares Fall as RBC Cuts Target and Melius Initiates Hold. Installed Building Products shares dropped alongside other industrial peers, partly due to RBC Capital lowering its price target to $208 and Melius Research initiating coverage with a Hold rating. While the stock is trading near its 52-week low, the average analyst target remains significantly higher at $239.92. The company also released its 2026 ESG report, but the recent focus has been on the mixed analyst outlook.